ENDRA LIFE SCIENCES INC. overview

ANN ARBOR, MI / ACCESSWIRE / September 7, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that management will participate in two upcoming virtual investment conferences. H.C. Wainwright 23 rd Annual Global Investment Conference, September 13 - 15, 2021. Management will deliver a company presentation and will be available for one-on-one meetings with investors in a virtual format. The recorded presentation will be available...

Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, MI / ACCESSWIRE / August 12, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today reported financial results for the three months ended June 30, 2021 and provided a business update. Highlights of the second quarter of 2021 and recent weeks include the following: Continued to screen patients at Rocky Vista University College of Osteopathic Medicine ("RVUCOM")....

ANN ARBOR, MI / ACCESSWIRE / August 2, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the second quarter of 2021 on Thursday, August 12, 2021 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer...

ANN ARBOR, MI / ACCESSWIRE / July 20, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that management will participate in A.G.P.'s Virtual MedTech Summer Conference on Thursday, July 29, 2021. The event will consist of 1-on-1 virtual investor meetings. Investors participating in the virtual conference who are interested in meeting with members of ENDRA's management team should contact their A.G.P. representative. About ENDRA...

ANN ARBOR, MI / ACCESSWIRE / June 15, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced the appointment of Irina Pestrikova as Senior Director of Finance and Principal Financial Officer. In this new position, Ms. Pestrikova will assume all day-to-day responsibilities previously performed by ENDRA's Chief Financial Officer David Wells, who will leave the Company effective June 18, 2021 to pursue another opportunity. Ms....

ANN ARBOR, MI / ACCESSWIRE / June 9, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that it is expected to be added to the Russell Microcap ® Index according to a preliminary list of additions posted on June 4. The addition of ENDRA to this Index will be finalized at the conclusion of the 2021 Russell indexes annual reconstitution and, if affirmed, will be effective after the U.S. market opens on June 28. "We are delighted...

Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, MI / ACCESSWIRE / May 17, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today reported financial results for the three months ended March 31, 2021 and provided a business update. Highlights of the first quarter of 2021 and recent weeks include the following: Began screening patients for real-world clinical validation of TAEUS at Rocky Vista University College...

ANN ARBOR, MI / ACCESSWIRE / May 6, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the first quarter of 2021 on Monday, May 17, 2021 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions. Participation...